Becton Dickinson (BDX) 8-K Current Report: February 25, 2026
Filed: February 25, 2026
Health Care
Surgical & Medical Instruments & ApparatusBecton Dickinson (BDX) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 8.01: Other Events
Becton Dickinson 8-K Feb 25, 2026 Event Analysis
Item 8.01 · Other Events
- • BDX running $2B aggregate tender offer across 15 debt series, buying back bonds at various maturities from 2026 to 2050
- • Early tender demand exceeded the $2B Aggregate Offer Cap, triggering proration on 3.794% Senior Notes due 2050
- • Largest early tenders: 4.669% Notes ($656M of $1.5B outstanding), 3.700% Notes ($699M of $1.725B outstanding), 4.685% Notes ($472M of $983M outstanding)
- • BDX upsized the Offer SubCap on 4.685% Senior Notes and raised the Aggregate Offer Cap, signaling stronger-than-expected bondholder participation
- • Debt management exercise likely funded by proceeds from BDX's previously announced spin-off or asset monetization — reduces interest burden on legacy high-coupon obligations
Get deeper insights on Becton Dickinson
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.